ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)

NCT04523129 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

834

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: CyclASol topical ocular, eye drops
DRUG: Vehicle topical ocular, eye drops

Sponsor

Novaliq GmbH